// App-Quantinova.ai

2295 : GDNF family receptor alpha 4 (GFRa4)-targeted adoptive T-cell immunotherapy for medullary thyroid carcinoma

Researchers

Presenter

  • Vijay G. Bhoj

Principal Investigators

  • Selene Nunez-Cruz

  • Kenneth Zhou

  • Dimitrios Arhontoulis

  • Michael Feldman

  • Keith Mansfield

  • Haiyong Peng

  • Christoph Rader

  • Don L. Siegel

  • Michael C. Milone

Medical Centers

  • University of Pennsylvania, Philadelphia, PA

  • The Scripps Research Institute, Jupiter, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medullary thyroid carcinoma

  • Thyroid Cancer

  • Solid malignancies

Biomarkers

  • High affinity nerve growth factor receptor

  • Hepatocyte growth factor receptor

  • Ret Proto-Oncogene

  • Glial cell-derived neurotrophic factor

Drug/Treatment

  • L-Tyrosine

  • GDNF

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A